Marshall Wace’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-40,828
Closed -$282K 2584
2024
Q2
$282K Buy
+40,828
New +$550K ﹤0.01% 2181
2022
Q3
Sell
-36,200
Closed -$1.12M 3411
2022
Q2
$1.12M Buy
+36,200
New +$963K ﹤0.01% 2374
2021
Q1
Sell
-116,992
Closed -$5.13M 2537
2020
Q4
$5.13M Buy
116,992
+2,057
+2% +$98K 0.03% 576
2020
Q3
$5.45M Buy
114,935
+34,287
+43% +$1.39M 0.03% 491
2020
Q2
$2.44M Buy
+80,648
New +$1.79M 0.02% 719
2019
Q3
Sell
-15,468
Closed -$282K 1705
2019
Q2
$282K Buy
+15,468
New +$245K ﹤0.01% 1191

Other funds holding CYRX

Marshall Wace's CYRX Position: Q3 2024 in Review

Marshall Wace sold out of CryoPort (CYRX) in Q3 2024, closing a stake of 40,828 shares — an estimated $282K sold.

Marshall Wace first reported a position in CYRX in Q2 2019 and held it in 6 quarters. The position peaked at $5.45M in Q3 2020. 152 funds tracked by Wall St. Rank hold CYRX as of Q3 2024.

  • Marshall Wace reported no remaining CryoPort position as of Q3 2024 after selling out during the quarter.
  • Marshall Wace sold 40,828 CryoPort shares in Q3 2024, an estimated $282K.
  • Marshall Wace first reported a position in CryoPort in Q2 2019 and held it in 6 quarters.
  • Marshall Wace's CryoPort position peaked at $5.45M in Q3 2020.
  • 152 funds tracked by Wall St. Rank held CryoPort as of Q3 2024.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.